Bristol Myers Squibb has released a new Press Release announcing that the European Medicines Agency (EMA) has validated the marketing authorization application for repotrectinib. Repotrectinib […]
+1 700 888 1234
Effingerstrasse 40 3008 Bern Switzerland
Bristol Myers Squibb has released a new Press Release announcing that the European Medicines Agency (EMA) has validated the marketing authorization application for repotrectinib. Repotrectinib […]
November 14th – 15th in Amsterdam We are delighted to announce that Lung Cancer Europe (LuCE) is participating in a two-day meeting […]
About the Organization Lungunion Austria The Lungunion Austria is a patient organization (NGO and self-aid organization) for people with airway […]
Join us for our upcoming webinar on “Coping with lung cancer diagnosis: Physical, social and emotional impact”.
🗓️ Date: 18 September 2023.
⏰ Time: 1-2 PM CET.
📍 Location: Online: LuCE social media channels.
LuCE will be actively participating in the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer #WCLC23 to be held in Singapore from 9-12 September 2023.
Our LuCE Executive Team members will be attending the European Respiratory Society (ERS) International Congress, to take place in Milan, Italy, on 9-12 September 2023.